FDA: Ozempic, Wegovy shortage over

(CNN)– The nationwide Ozempic shortage is over.

On Friday, Feb. 21, the Food and Drug Administration said there is no longer a short supply of the weight loss and diabetes drugs Wegovy and Ozempic.

Increased demand has led to a shortage since 2022.

In a statement, drug maker Novo Nordisk said it’s now meeting or exceeding current and projected nationwide demand.

The company also warned about knockoff versions of the drugs.

When drugs are in short supply, there is a law that allows compounding pharmacies to step in and fill the supply gaps.